期刊文献+

TSA对人肝癌细胞株E-cadherin启动子区甲基化及表达的影响

Effects of TSA on promoter methylation and expression of E-cadherin gene in hepatocellular carcinoma cell lines
原文传递
导出
摘要 目的探讨去乙酰化转移酶抑制剂TSA对人肝癌SMMC-7721细胞株E-cadherin基因(E-cad)启动子区甲基化及其表达的影响。方法TSA(300nm/L)处理人肝癌SMMC-7721细胞,MTT法、TUNEL染色法分别检测细胞生长抑制及凋亡情况,甲基化特异性的PCR(methylation-specific PCR,MSP)检测处理前后E-cad启动子区CpG岛甲基化状态;Western blot检测处理前后E-cad及DNMT3b表达水平的变化。结果TSA能抑制人肝癌SMMC-7721细胞生长并诱导其发生凋亡,与对照组相比,实验组细胞生长抑制率为21.85%,对照组细胞凋亡率为(4.69±0.56)%,实验组凋亡率为(14.94±0.91)%,与对照组相比,凋亡细胞明显增多(P=0.000)。用药前E-cad启动子区CpG岛为甲基化状态,E-cad蛋白表达阴性。TSA处理后E-cad启动子区CpG岛发生脱甲基化,E-cad蛋白恢复表达。TSA亦导致DNMT3b的表达水平降低。结论去乙酰化转移酶抑制剂TSA能抑制人肝癌SMMC-7721细胞生长,并可诱导其发生凋亡,逆转E-cad基因启动子区的甲基化状态,并恢复该基因表达。TSA有可能通过DNMT3b发挥脱甲基化作用。 Objective To study the effects of histone deacertylase inhibitor (TSA) on promoter methylation and expression of E-cadherin gene in a hepatocellular carcinoma cell line SMMC7721. Methods Hepatocellular carcinoma cell line SMMC-7721 was treated with TSA(300nm/L), MTT method was used to investigate the growth inhibition ratio, TUNNL was conducted to measure the apoptosis ratio, methylation-specific PCR(MSP) was employed to detect changes in the CpG island methylation of E-cad promoter region, Western blot technique was used to detect the expression of E-cad gene and DNMT3b before and after TSA treatment, respectively. Results TSA decreases the SMMC-7721 cell viability and induces apoptosis, the growth inhibition ratio was 21.85% compared with control group. The apoptosis ratio of control group was (4.69±0.56)%, the apoptosis ratio of TSA treatment group was(14.94±0.91)%. The apoptosis ratio of TSA treatment group was significantly higher than that of control group (P=0.000). Before treated with TSA, the CpG island of E-cad promoter region was methylated, and the expression of E-cad was negative. TSA treatment induces demethylation of the CpG island in E-cad promoter region, causes the re-expression of E-cad. TSA reduces the expression of DNMT3b. Conclusions TSA decreases the SMMC-7721 cell viability and induces apoptosis, reverses the methylation status of E-cad promoter region, and resumes E-cad gene expression. TSA may induce demethylation through down-regulating the expression of DNMT3b.
出处 《中华普通外科杂志》 CSCD 北大核心 2009年第3期230-233,共4页 Chinese Journal of General Surgery
基金 国家自然科学基金资助项目(30571814)
关键词 肝细胞 甲基化 DNA修饰甲基酶类 曲古抑菌素A 上皮型钙黏素 Carcinoma, hepatocellular Methylation DNA modification methylases Trichostatin A E-cadherin
  • 相关文献

参考文献17

  • 1Ou JN, Torrisani J, Alexander U, et al. Histone deacetylase inhibitor trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol, 2007 : 1297-1307.
  • 2刘维民,闫凯麟,吴智群.TSA对人肝癌细胞SMMC-7721的抑制作用及其机制[J].现代肿瘤医学,2007,15(10):1373-1375. 被引量:8
  • 3Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA,1996,93:9821-9826.
  • 4Das PM, Singal R. DNA methylation and cancer. J Clin Oncol, 2004, 22: 4632-4642.
  • 5Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature,2004,429:457-463.
  • 6Shen XD, Kramer RH. Adhesion- mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol, 2004, 165: 1315-1329.
  • 7Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas, J Natl Cancer Inst ,2000,92:569-573.
  • 8Iwata N, Yamamoto H, Sasaki S, et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma, Oncogene, 2000, 19: 5298- 5302.
  • 9Monneret C. Histone deacetylase inhibitors . Eur J Med Chem, 2005 ,40:1-13.
  • 10Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev, 1999,9:40- 48.

二级参考文献13

  • 1赵洁,苏琦.组蛋白乙酰化/去乙酰化与白血病的研究进展[J].肿瘤学杂志,2004,10(6):436-439. 被引量:19
  • 2喻建华,万会平.原发性肝癌的介入治疗及其预后的影响因素[J].肿瘤防治杂志,2004,11(12):1309-1312. 被引量:3
  • 3Wang JJ,Chang YF,Chern YT,et al.Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy) phenyl]diamantane (DPD),a novel cytostatic and differentiation inducing agent,on human colon cancer cells[J].Br J Cancer,2003,89(10):1995 -2003.
  • 4Monneret C.Histone deacetylase inhibitors[J].Eur J Med Chem,2005,40(1):1 - 13.
  • 5Roy S,Packman K,Jeffrey R,et al.Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells[J].Cell Death Differ,2005,12:482 - 491.
  • 6Duan H,Heckman CA,Boxer LM.Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas[J].Mol Cell Biol,2005,25(5):1608-1619.
  • 7Chiba T,Yokosuka O,Fukai K,et al.Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor,trichostatin A,on human hepatoma cells[J].Oncology,2004,66(6):481 -491.
  • 8Juan LJ,Shia WJ,Chen MH,et al.Histone deacetylases specifically down-regulate p53-dependent gene activation[J].J Biol Chem,2000,275 (27):20436 - 20443.
  • 9Chiba T,Yokosuka O,Arai M,et al.Identification of genes upregulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells[J].J Hepatol,2004,41 (3):436 - 445.
  • 10陈坚,张晓琴,傅继梁.组蛋白乙酰化/脱乙酰化与细胞周期的关系[J].国外医学(遗传学分册),2000,23(5):233-236. 被引量:5

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部